Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
Transplantation, 08/31/2011
Clinical Article
Billing H et al. – This pilot study demonstrates that Chronic antibody–mediated rejection in pediatric renal transplant recipients can be treated successfully and safely with a combination of intravenous immunoglobulin and rituximab. This observation should encourage more extensive studies to evaluate this new treatment strategy.






